CompletedNCT03693378
A Study of IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups
Studying Familial atypical multiple mole melanoma syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Immunovia, Inc.
- Principal Investigator
- Rolf EhrnströmImmunovia, Inc.
- Enrollment
- 1349 enrolled
- Eligibility
- All sexes
- Timeline
- 2016 – 2021
Study locations (21)
- Stanford Gastroenterology and Hepatology, Stanford, California, United States
- Yale University, New Haven, Connecticut, United States
- University of Chicago Medical Center, Chicago, Illinois, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- University of Massachusetts, Worcester, Massachusetts, United States
- New York University Hospital, New York, New York, United States
- Columbia University, New York, New York, United States
- Mount Sinai Hospital, New York, New York, United States
- The Ohio State University, Columbus, Ohio, United States
- Oregon Health & Science University, Portland, Oregon, United States
- University of Pennsylvania, Philadelphia, Pennsylvania, United States
- University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
- University of Utah, Salt Lake City, Utah, United States
- The Research Institute of the McGill University Health Centre, Montreal, Canada
- University Hospital Ramon y Cajal, Madrid, Spain
- +6 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03693378 on ClinicalTrials.govOther trials for Familial atypical multiple mole melanoma syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06599619Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic NeviJohn Kirkwood
- RECRUITINGNCT04095195Registry of Subjects at Risk of Pancreatic CancerAssociazione Italiana per lo Studio del Pancreas
- RECRUITINGNCT05446155BioMEL- Diagnostic and Prognostic Factors in Melanoma.Region Skane
- RECRUITINGNCT00040352Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of MelanomaNational Cancer Institute (NCI)
See all trials for Familial atypical multiple mole melanoma syndrome →